(Q26863402)

language of work or name

1 reference

May 2014

1 reference

1 reference

10

1 reference

PubMed

page(s)

1095-111

1 reference

PubMed

issue

6

1 reference

Surgical pathology of renal epithelial neoplasms: recent advances and current status

PubMed

cites work

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.258

Sorafenib in advanced clear-cell renal-cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.258

Treatment selection in metastatic renal cell carcinoma: expert consensus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.258

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.258

Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.258

Differential diagnosis of renal tumors with clear cytoplasm: clinical relevance of renal tumor subclassification in the era of targeted therapies and personalized medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.258

Evaluation of treatment options for patients with advanced renal cell carcinoma: assessment of appropriateness, using the validated semi-quantitative RAND corporation/University of California, Los Angeles methodology

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.258

Treating the individual: The need for a patient-focused approach to the management of renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.258

Molecular and cytogenetic insights into the pathogenesis, classification, differential diagnosis, and prognosis of renal epithelial neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.258

Integrated molecular analysis of clear-cell renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.258

Prognostic factors and clinical trials of new agents in patients with metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.258

Prognostic factors for progression-free and overall survival with sunitinib targeted therapy and with cytokine as first-line therapy in patients with metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.258

Prognostic factors for survival in 1059 patients treated with sunitinib for metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.258

Erythrocyte sedimentation rate and anaemia are independent predictors of survival in patients with clear cell renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.258

EAU guidelines on renal cell carcinoma: the 2010 update

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.258

Prognostic factors and predictive models in renal cell carcinoma: a contemporary review

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.258

Urinary biomarkers for the early diagnosis of kidney cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.258

Urine screening by Seldi-Tof, followed by biomarker identification, in a Brazilian cohort of patients with renal cell carcinoma (RCC).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.258

Differential protein profiling of renal cell carcinoma urinary exosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.258

Urine metabolomics analysis for kidney cancer detection and biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.258

Guideline for management of the clinical T1 renal mass

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.258

Preoperative imaging in renal cell cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.258

Molecular imaging and carbonic anhydrase IX-targeted radioimmunotherapy in clear cell renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.258

Pilot study evaluating use of lymphotrophic nanoparticle-enhanced magnetic resonance imaging for assessing lymph nodes in renal cell cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.258

Advanced renal mass imaging: diffusion and perfusion MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.258

Estrogen receptor α is a novel target of the Von Hippel-Lindau protein and is responsible for the proliferation of VHL-deficient cells under hypoxic conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.258

Significance of ADC value for detection and characterization of urothelial carcinoma of upper urinary tract using diffusion-weighted MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.258

EADC Values in Diagnosis of Renal Lesions by 3.0 T Diffusion-Weighted Magnetic Resonance Imaging: Compared with the ADC Values

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.258

Unusual metastatic sites from renal cell carcinoma detected by 18F-FDG PET/CT scan

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.258

Integrated optical coherence tomography and optical coherence microscopy imaging of ex vivo human renal tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.258

Optical spectroscopy techniques can accurately distinguish benign and malignant renal tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.258

Microfoam formation in a capillary.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.258

BR55: a lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.258

Contrast-enhanced high-frequency ultrasound imaging of early stage liver metastasis in a preclinical mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.258

ImmunoPET imaging of renal cell carcinoma with (124)I- and (89)Zr-labeled anti-CAIX monoclonal antibody cG250 in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.258

The value of preoperative needle core biopsy for diagnosing benign lesions among small, incidentally detected renal masses

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.258

Treatment of patients with metastatic renal cell cancer: a RAND Appropriateness Panel.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.258

Robotic-assisted partial Nephrectomy: initial experience in South America.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.258

Renal tumor biopsies for evaluation of small renal tumors: why, in whom, and how?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.258

Optimizing treatment for patients with metastatic renal cell carcinoma in the Central and Eastern European region.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.258

Rationale for percutaneous biopsy and histologic characterisation of renal tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.258

Renal tumors with clear cells. A review.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.258

An overview of renal cell cancer: pathology and genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.258

Current pathology keys of renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.258

Risk and prognosis in renal neoplasms. A pathologist's prospective

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.258

Detecting circulating tumor cells: current challenges and new trends

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.258

Miniaturized nuclear magnetic resonance platform for detection and profiling of circulating tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.258

Simultaneous capture and in situ analysis of circulating tumor cells using multiple hybrid nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.258

Microfluidic bead-based multienzyme-nanoparticle amplification for detection of circulating tumor cells in the blood using quantum dots labels.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.258

Molecular genetics of human renal cell tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.258

Genetic clustering of clear cell renal cell carcinoma based on array-comparative genomic hybridization: its association with DNA methylation alteration and patient outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.258

Genomic copy number alterations in clear cell renal carcinoma: associations with case characteristics and mechanisms of VHL gene inactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.258

Genome-wide profiling of chromosomal alterations in renal cell carcinoma using high-density single nucleotide polymorphism arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.258

Gene expression profiling of clear cell renal cell carcinoma: gene identification and prognostic classification

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.258

Integrative genome-wide gene expression profiling of clear cell renal cell carcinoma in Czech Republic and in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.258

Comprehensive molecular characterization of clear cell renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.258

Differencial proteome of clear-cell renal cell carcinoma (ccRCC) tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.258

Proteomic analysis of signaling network regulation in renal cell carcinomas with differential hypoxia-inducible factor-2α expression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.258

Imaging the clear cell renal cell carcinoma proteome.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.258

Quantitative proteomic analysis in metastatic renal cell carcinoma reveals a unique set of proteins with potential prognostic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.258